Interferon therapy and autoimmunity;Interferontherapie und Autoimmunitat

Medizinische Klinik

Volumn 92, Issue 5, 1997, Pages 265-272

  Fritzsch, Jörg ^a,b   Krug, Jürgen ^a   Heberling, Hans Jürgen ^a  

^a Stadtkrankenhaus Leipzig   (Germany)

^b Stadtkrankenhaus   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA2A INTERFERON; ALPHA2B INTERFERON; GAMMA INTERFERON; INTERFERON;

AUTOIMMUNITY; CANCER; DISEASE COURSE; DRUG SAFETY; DRUG TOXICITY; FOLLOW UP; HEPATITIS VIRUS; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; REVIEW; SIDE EFFECT; VIRUS HEPATITIS; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNE THYROIDITIS; CHEMICALLY INDUCED DISORDER; COLLAGEN DISEASE; DRUG EFFECT; INCIDENCE; LYMPHOCYTE; NEOPLASM; THROMBOCYTOPENIA;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; AUTOIMMUNE DISEASES; COLLAGEN DISEASES; HEPATITIS, VIRAL, HUMAN; HUMANS; INCIDENCE; INTERFERONS; LYMPHOCYTES; MAJOR HISTOCOMPATIBILITY COMPLEX; NEOPLASMS; THROMBOCYTOPENIA; THYROIDITIS, AUTOIMMUNE;

EID: 0030990284     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03045081     Document Type: Review

References (102)

1. Abdi, E. A., W. Brien, P. M. Vermer: Auto-immune thrombocytopenia. related to interferon therapy. Scand. J. Haemat. 36 (1986), 515-519.
2. Akard, L. P , R. Hoffmann, L. Elias, J. H. Saiers: Alpha-interfernon and immune hemolytic anemia. Ann. intern. Med. 105 (1986), 306.
3. Ariad, S., E. Song, R. Cohen, W. R. Bezwoda: Interferon-alpha induced autoimmune hepatitis in a patient with Philadelphia chromosome-positive chronic myeloid leukemia with cytogenerically normal T lymphocytes. Mol. Biother. 4 (1992), 139-142.
4. Atkins, M. B., J. W. Mier, D. R. Parkinson, J. A. Gould, E. M. Berkman, M. M. Kaplan: Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells. New Engl. J. Med. 318 (1988), 1557-1563.
5. Bankhurst, A. D.: Interferons and systemic lupus erythematosus. J. Rheum. 14, Suppl. 13 (1987), 63-67.
6. Barreca, T., A. Picciotto, R. Franceschini, G. Varagona, G. Corsini, F. Valle, A. Cataldi, E. Molinari, A. Garibaldi, E. Rolandi: Long term therapy with recombinant interferon alpha 2b in patients with chronic hepatitis C: Effects on thyroid function and autoantibodies. J. biol. Regul. homeost. Agents 7 (1993), 58-62.
7. Baudin, E., P. Marcellin, M. Pouteau, N. Colas-Linhart, J.-P. Le Floch, C. Lemmonier, J.-P. Benhamou, B. Bok: Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C. Clin. Endocr. 39 (1993), 657-661.
8. Becker, J. C., B Winkler, S. Klingert, E.-B. Bröcker: Antiphospholipid syndrome associated with immunotherapy for patients with melanoma. Cancer 73 (1994), 1621-1624.
9. Beck-Peccoz, P., D. Preziati, R. Marcelli, L. Persani, M. G. Rumi, E. Del Ninno, G. Faglia: High incidence of thyroid autoimmunity in patients with chronic hepatitis C: Effects of treatment with recombinant human interferon α-2a (rhIFNα). J. endocr. Invest 15, Suppl. 2 (1992), 121.
10. Bellone, J. D., T. J. Kumcki, R. H. Aster: Immune thrombocytopenia associated with carcinoma. Ann. intern. Med. 99 (1983), 470-472.
11. Berns, B., S. V. Feinman: Thyroid dysfunction and liver injury following alpha-interferon treatment of chronic viral hepatitis. Dig. Dis. Sci. 36 (1991), 1657-1660.
12. Bhakri, H., K. Sriskandan, T. Davis, K. Pettingale, D. Tee: Recombinant gamma interferon and autoimmune thyroid disease. Lancet 2 (1985), 457.
13. Bottazzo, G. F., R. Pujol-Borrell, T. Hanafusa, M. Feldmann: Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 2 (1983), 1115-1118.
14. Braathen, L. R., P. Stavem: Autoimmune haemolytic anaemia associated with interferon alfa-2a in patient with mycosis fungoides. Brit. med. J. 298 (1989), 1713.
15. Burman, P., T. H. Tötterman, K. Öberg, F. A. Karlsson: Thyroid autoimmunity in patients on long term therapy with leucocyte-derived interferon. J. clin. Endocr. Metab. 63 (1986), 1086-1090.
16. Chan, G. C. B., S. S. Lee, E. K. Yeoh: Mono-arthritis in a chronic hepatitis B patient after α-interferon treatment. J. Gastroent. Hepatol 7 (1992), 432-433.
17. Chazerain, P., O. Meyer, P. Ribard, M. De Brandt, C. Mechelany, P. Marcellin, J. F. Bernard, M. Grossin, M. F. Kahn: Trois cas de polyarthrite survenant au cours d'un traitement par interféron-alpha recombinant. Rev. Rhum. Mal. Ostéoartic. 59 (1992), 303-309.
18. Chung, Y.-H., Y. K. Shong: Development of thyroid autoimmunity after administration of recombinant human interferon-α2b for chronic viral hepatitis. Amer J. Gastroent. 88 (1993), 244-247.
19. Conlon, K. C., W. J Urba, J. W. Smith, R. G. Steis, D. L. Longo, J. W. Clark: Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy. Cancer 65 (1990), 2237-2242.
20. Demeter, J., K. Pálóczi, D. Lehoczky, M. Høier-Madsen, A. Wiik: Autoantibody occurrence in hairy cell leukemia. Haematologica 78 (1993), 287-290.
21. Derwahl, M.: Cytokine und Autoimmunthyreoiditis. Nuklearmediziner 16 (1993), 225-230.
22. D'Hondt, L., A. Delannoy, C. Docquier: Hypothyroidism and arthritis during interferon therapy. Clin. Rheum. 12 (1993), 415-417.
23. Eisenburg, J.: Interferon- oder Virus-C-induzierte autoimmune chronische Hepatitis? Fortschr. Med. 112 (1994), 317-321.
24. Fabris, P., C. Betterle, A. Floreani, N. A. Greggio, F. De Lazzari, R. Naccarato, M. Chiaramonte: Development of type 1 diabetes mellitus during Interferon alfa therapy for chronic HCV hepatitis. Lancet 340 (1992), 548.
25. Fattovich, G., C. Betterle, L. Brollo, B. Pedini, G. Giustina, G. Realdi, A. Alberti, A. Ruol: Autoantibodies during α-interferon therapy for chronic hepatitis B. J. med. Virol. 34 (1991), 132-135.
26. Fentiman, I. S., F. R. Balkwill, B. S. Thomas, M. J. Russell, I. Todd, G. F. Bottazzo: An autoimmune aetiology for hypothyroidism following interferon therapy for breast cancer. Europ. J. Cancer clin. Oncol. 24 (1988), 1299-1303.
27. Fonseca, V., M. Thomas, G. Dusheiko: Thyrotropin receptor antibodies following treatment with recombinant α-interferon in patients with hepatitis. Acta endocr. (Kbh.) 125 (1991), 491-493.
28. Fornacian, G., C. Bassi, M. Beltrami, E. Castagnetti, S. Maccari, A. C. Plancher: Hemolytic anemia secondary to interferon treatment for chronic B hepatitis. J. clin. Gastroent. 13 (1991), 596-597.
29. Funk, J., T. Langeland, E. Schrumpf, L. E. Hanssen: Psoriasis induced by interferon-α. Brit. J. Derm. 125 (1991), 463-465.
30. Giles, F. J , C. P. Worman, A. P. Jewell, A. H. Goldstone: Recombinant alpha-interferons, thyroid irradiation and thyroid disease Acta haemat. 85 (1991), 160-163.
31. Gisslinger, H., B. Gilly, W. Woloscuk, W. R. Mayr, L. Havelec, W. Linkesch, M. Weissel: Thyroid autoimmunity and hypothyroidism. during long-term treatment with recombinant interferon-alpha. Clin. exp. Immunol. 90 (1992), 363-367.
32. Graninger, W. B., W. Hassfeld, B. B. Pesau, K. P. Machold, C. C. Zielinski, J. S. Smolen: Induction of systemic lupus erythematosus by interferon-γin a parient with rheumatoid arthritis. J. Rheum. 18 (1991), 1621-1622.
33. Gutterman, J. U.: Review - Cytokine therapeutics: lessons from interferon a. Proc. nat. Acad. Sci. (Wash.) 91 (1994), 1198-1205.
34. Harrison, P. V., M. J. Peat. Effect of interferon on psoriasis. Lancet 2 (1986), 457-458.
35. Hartmann, F., P. von Wussow, H. Deicher: Psoriasis-Exazerbation bei Therapie mit α-Interferon. Dtsch. med. Wschr. 114 (1989), 96-98.
36. Jacobs, E. L , M. Clare-Salzler, I. J. Chopra, R. A. Figlin: Thyroid function abnormalities associated with the chronic outpatient administration of recombinant interleukin-2 and recombinant interferon-alpha. J. Immunother. 10 (1991), 448-455.
37. Jucgla. A., J. Marcoval, N. Curco, O. Servitje: Psonasis with articular involvement induced by interferon alfa. Arch. Derm. 127 (1991), 909-910.
38. Kaboth, U., W. Hiddemann: Paraneoplastische Syndrome. Internist (Berl.) 35 (1994), 1175-1180.
39. Kälkner, M., H. Hagberg, A. Karlsson-Parra: Autoantibody occurrence in hairy-cell leukemia during prolonged interferon treatment. Europ. J. Haematol. 45 (1990), 233-234.
40. Kanfer. J., D.M. McCarthy: Immune thrombocytopenia and interferon alfa. Brit. med. J. 297 (1988), 1613.
41. Karlsson, F. A., P. Burman, K. Oberg, A. Karlsson-Parra: Thyroid autoimmunity induced by interferon therapy. In: Scherbaum, W. A., U. Bogner, B. Weinheimer, G. F. Bottazzo: Autoimmune thyroiditis. Approaches towards its etiological differentiation. Springer, Berlin - Heidelberg-New York 1991, p. 293-296.
42. Karlsson-Parra, A., P. Burman, H. Hagberg, K. Öberg, G. Alms, L. Klareskog, F. A. Karlsson: Autoantibodies to epithelial cells in patients on long-term therapy with leucocyte-derived interferon-α (IFN-α). Clin. exp. Immunol. 81 (1990), 72-75.
43. Kawamaki, Y., N. Kuzuya, T. Watanabe, Y. Uchiyama, K. Yamashita: Induction of experimental thyroiditis in mice by recombinant interferon γ administration. Acta endocr. (Kbh.) 122 (1990), 41-48.
44. Knop, J., B. Taborski, J. de Maeyer-Guignard: Selective inhibition of the generation of T suppressor cells of contact sensitivity in vitro by interferon. J. Immunol. 138 (1987), 3684-3687.
45. Kodama, T., S Katabami, K. Kamijo, A. Katanuma, K. Yamashita, N. Azuma, T. Tamaki, A. Yacht: Development of transient thyroid disease and reaction during treatment of chronic hepatitis C with interferon. J. Gastroent. 29 (1994), 289-292.
46. Krug, J., J. Fritzsch, G. Aust: Induction of insulin antibodies and insulin allergy under alpha-interferon treatment of renal cell carcinoma in a patient with insulin-treated diabetes mellitus - a case report. Int. Arch. Allergy Immunol. 106 (1995), 169-172.
47. Kung, A. W. C., B. M. Jones, C. L. Lai: Effects of interferon-γ therapy on thyroid function, T-lymphocyte subpopulations and induction of autoantibodies. J. clin. Endocr. Metab. 71 (1990), 1230-1234.
48. Kušec, R., S. Ostoijic, A. Planinc-Peraica, H. Minigo, B. Jaksic: Exacerbation of psoriasis after treatment with alpha-interferon. Dermatologies 181 (1990), 170.
49. Larrey, D., P. Marcellin, E. Frenaux, D. Pessayre, J -P. Benhamou: Exacerbation of multiple sclerosis after the administration of recombinant human interferon alfa. J. Amer. med. Ass. 261 (1989), 2065.
50. Lisker-Melrnan, M., A. M. Di Bisceglie, S. J. Usala, B. Weintraub, L. M. Murray, J. H. Hoofnagle: Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa. Gastroenterology 102 (1992), 2155-2160.
51. López Morante, A. J., F. Saéz-Royuela, F. Casanova Valero, L. Yuguero del Moral, J. L. Martin Lorente, C. Ojeda Giménez: Immune thrombocytopenia after α-interferon therapy in a patient with chronic hepatitis C. Amer. J. Gastroent. 87 (1992), 809-810.
52. Maccan, S., C. Bassi, A. G. Giovannini, A. C. Plancher: A case of arthropathy and hypothyroidism during recombinant alpha-interferon. therapy. Clin. Rheum. 10 (1991), 452-454.
53. Manns, M. P., K. H. W. Böker: Was ist gesichert in der Therapie der chronischen Virushepatitis? Internist (Berl.) 34 (1993), 1096-1106.
54. Marcais, O., B. Hanslik, F. Coste, P. Perney, J. Clot, F. Blanc: Anomalies biologiques autoimmunes chez 35 malades atteints d'hépatite chronique virale C traités pendant six mois par interféron (IFN) et suivis pendant un an. Rev. Med. intern. 14 (1993), 1009.
55. Marcellin, P., M. Poteau, P. Renard, J.-M. Grynblat, N. Colas Linhart, P. Bardet, B. Bok, J.-P. Benhamou: Sustained hypothyroidism induced by recombinant α interferon in patients with chronic hepatitis C. Gut 33 (1992), 855-856.
56. Matthey, F., S. Ardeman, L. Jones, A. C. Newland: Bleeding in immune thrombocytopenic purpura after alpha-interferon Lancet 335 (1990), 471-472.
57. Mayet, W.-J., G. Hess, G. Gerken, S. Rossol, R. Voth, M. Manns, K.-H. Meyer zum Büschenfelde: Treatment of chronic type B hepatitis with recombinant α-interferon induces autoantibodies not specific for auto-immune chronic hepatitis. Hepatology 10 (1989), 24-28.
58. McLaughlin, P., M. Talpaz, J. R. Quesada, A. Saleem, B. Barlogie, J. U. Gutterman: Immune thrombocytopenia following α-interferon therapy in patients with cancer. J. Amer. med. Ass. 254 (1985), 1353-1354.
59. Mehta, N. D., A. L. Hooberman, E. E. Vokes, S. Neeley, S. Coder: 35-Year-old patient with chronic myelogenous leukemia developing systemic lupus erythematosus after α-interferon therapy. Amer. J. Hematol. 41 (1992), 141.
60. Morikawa, K., H. Kubagawa, T. Suzuki, M. D. Cooper: Recombinant Interferon-α, -β and -γ enhance the proliferative response of human B cells. J. Immunol. 139 (1987), 761-766.
61. Nicolas, J.-F., J. Thivolet. Interferon alfa therapy in severe unresponsive subacute cutaneous lupus erythematosus. New Engl J. Med. 321 (1989), 1550-1551.
62. Niizeki, H., N. Inamoto, K. Nakamura, K. Tsuchimoto, T. Hashimoto, T. Nishikawa: A case of pemphigus foliaceus after interferon alpha-2a therapy. Dermatology 189, Suppl. 1 (1994), 129-130.
63. Öberg, K., G Alm, A. Magnusson, G. Lundquisr, E. Theodorsson, L. Wide, E. Wilander: Treatment of malignant carcinoid tumors with recombinant interferon alfa-2b: Development of neutralizing interferon antibodies and possible loss of antitumor activity. J. nat. Cancer Inst. 81 (1989), 531-535.
64. Obert, H.-J., P. H. Hofschneider: Interferon bei chronischer Polyarthritis. Dtsch. med. Wschr. 110 (1985), 1766-1769.
65. O'Connell, P. G., L. H. Gerber, J. H. Digiovannova, G. L. Peck: Arthritis in patients with psoriasis treated with gamma-interferon. J. Rheum. 19 (1992), 80-82.
66. Pagliacci, M. C., G. Pelicci, M. Schippa, A. M. Liberati, I. Nicoletti: Does interferon-β induce thyroid autoimmune phenomena? Horm. Metab. Res. 23 (1991), 196-197.
67. Panitch, H. S., R. L. Hirsch, J. Schindler, K. P.Johnson: Treatment of multiple sclerosis with gamma interferon: Exacerbations associated with activation of the immune system. Neurology (Minneap.) 37 (1987), 1097-1102.
68. Papo, T., P. Marcellin, J. Bernuau, F. Durand, .T. Poynard, J.-P. Benhamou: Autoimmune chronic hepatitis exacerbated by alpha-interferon. Ann. intern. Med. 116 (1992), 51-53.
69. Parodi, A., M. Semino, R. Gallo, A. Rebora: Bullous eruption with circulating pemphigus-like antibodies following interferon-alpha therapy. Dermatology 186 (1993), 155-157.
70. Pateron, D., I. Augier, J. C. Duclos-Vallée, H. Jouanolle, D.J. Hartmann, M. Beaugrand: High prevalence of abnormal thyroid tests in patients with chronic hepatitis C (CHC) before alpha interferon (IFN) therapy: Relation with IFN induced thyroid dysfunction. Hepatology 14 (1991), 77a.
71. Perez, R., K. Padavic, R. Krigel, L. Weiner: Antierythrocyte autoantibody formation after therapy with interleukin-2 and gamma-interferon. Cancer 67 (1991), 2512-2517.
72. Peters, M.: Mechanisms of action of interferon. Semin Liver Dis. 9 (1989), 5-9.
73. Quesada, J. R., J. U. Guttennan: Psoriasis and alpha-interferon. Lancet 1 (1986), 1466-1468.
74. Rabinowitz, A. P., E. Hu, K. Watkins, A. Mazumder: Hemolytic anemia in a cancer patient treated with recombinant interferon-γ. J. biol. Response Mod. 9 (1990), 256-259.
75. Radin, A. I., P. Buckley, T. P. Duffy: Interferon therapy for agnogenic myeloid metaplasia complicated by immune hemolytic anemia. Hematol. Path. 5 (1991), 83-88.
76. Rönnblom. L. E., G V. Aim, K. E. Oberg: Possible induction of systemic lupus erythematosus by interferon-α treatment in a patient with a malignant carcinoid tumor. J. intern Med. 227 (1990), 207-210.
77. Rönnblom, L. E., G. V. Alm, K.Öberg: Autoimmune phenomena in patients with malignant carcinoid tumors during interferon-α treatment. Acta oncol. (Madr.) 30 (1991), 537-540.
78. Saracco, G., A. Touscoz, M. Durazzo, F. Rosina, E. Donegani, L. Chiandussi, V. Gallo, R. Petrino, A. G. De Micheli, A. Solmas, A. Deplano, A. Tocco, P. A. Cossu, C. Pintus, G. Verme, M. Rizzetto: Autoantibodies and response to α-interferon in patients with chronic viral hepatitis. J. Hepatol. 11 (1990), 339-343.
79. Sauter, N. P., M. B. Atkins, J. W. Mier: Transient thyrotoxicosis and persistent hypothyroidism due to acute autoimmune thyroiditis after interleukin-2 and interferon-α therapy for metastatic carcinoma: A case report. Amer. J. Med. 92 (1992), 441-444.
80. Schattner, A.: Lymphokines in autoimmunity-a critical review. Clin. Immunol. Immunopath. 70 (1994), 177-189.
81. Schilling, P. J., R. Kurzrock, H. Kantarjian, J. U. Gutterman, M. Talpaz; Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia. Cancer 68 (1991), 1536-1537.
82. Schultz, M., R. Müller, A. von zur Mühlen, G. Brabant: Induction of hyperthyroidism by interferon-β-2b. Lancet 1 (1989), 1452.
83. Seitz, M., M. Franke, H. Kirchner: Induction of antinuclear antibodies in patients with rheumatoid arthritis receiving treatment with human recombinant interferon gamma. Ann. rheum. Dis. 47 (1988), 642-644.
84. Shindo, M., A. M. Di Bisceglie, J. H. Hoofnagle: Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C. Gastroenterology 102 (1992), 1406-1408.
85. Silva, M. O., K. R. Reddy, L. J. Jeffers, M. Hill, E. R. Schiff Interferon-induced chronic active hepatitis? Gastroenterology 101 (1991). 840-842.
86. Stricker, R. B., B. Barlogie, D. B. Kiprov: Acquired factor VIII inhibitor associated with chronic interferon-α-therapy. J. Rheum. 21 (1994), 350-352.
87. Taniguchi, Y., T. Murakaini, K. Nakanishi, M. Tamai, B. Matsuura, T. Masumoto, M. Onji, J. Tajin, S. Noguchi, Y. Ohca: Two cases of hypothyroidism associated with alpha-interferon therapy. Intern. Med. 31 (1992), 373-376.
88. Todd, I., V. Guerin, G. F. Bottazzo: Blocking the induction of HLA class II expression by thyroid epithelial cells in vitro. In: Scherbaurn, W. A., U. Bogner, B. Weinheimer, G. F. Bottazzo: Autoimmune thyroiditis. Approaches towards its etiological differentiation. Springer, Berlin - Heidelberg - New York 1991, p. 239-246.
89. Tolaymat, A., B. Leventhal, A. Sakarcan, H. Kashima, C. Monteiro: Systemic lupus erythernatosus in a child receiving long-term interferon therapy. J. Pediat. 120 (1992), 429-432.
90. Tran, A., C. Beusnel, M.-L. Montoya, V. Lussiez, X. Hébuterne, P. Rampal: Hépatite auto-immune de type 1 révélée par un traitement par interféron. Gastroent. clin. Biol. 16 (1992), 722-723.
91. Tran, A., J -F. Quaranta, S. Benzaken, V. Thiers, H. T. Chau, P. Hastier, D. Regnier, G. Dreyfus, C. Pradier, J.-L. Sadoul, X Hébuterne, P. Rampai: High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology 18 (1993), 253-257.
92. Ueda, H., A. Ishikawa, S. Itoh, M. Kusaka, H. Azuma, T. Suzuki, N. Takasaki, K. Isurugi, N. Ueno, A. Demura: Hypothyroidism followed by interferon-alpha as adjuvant therapy of renal cell carcinoma: a case report (Zusammenfassung). Hinyokika-Kiyo 38 (1992), 1165-1169.
93. Ueki, K., A. Tsuchida, H. Murakami, S. Yano, N. Kobayashi, M. Omine, T. Naruse: Hypoparathyroidism during α-interferon therapy in a patient with multiple myeloma. J. Med. 20 (1989), 391-397.
94. Ueno, Y., T. Sohma: Alpha-interferon-induced nodular rheumatoid arthritis in renal cell carcinoma. Ann. intern. Med. 117 (1992), 266-267.
95. Van Liesum, P. A., P. H. M. De Mulder, E. J. M. Mattijssen, F. H. M. Corstens, D. J. T. Wagener: Hypothyroidism and goitre during interleukin-2 therapy without LAK cells. Lancet 1 (1989), 224.
96. Vento, S., G. Di Pern, T. Garofano, L. Cosco, E. Concia, T. Ferraro, D. Bassetti: Hazards of interferon therapy for HBV-seronegative chronic hepatitis. Lancet 2 (1989), 926.
97. Vial, T., J. Descotes: Clinical toxicity of the interferons. Drug Saf. 10 (1994) 115-150.
98. Wagun, M., T. Hanafusa, N. Itoh, A. Imagawa, J. Miyagawa, S. Kawata, N. Kono, M. Kuwajima, Y Matsuzawa: Occurence of IDDM during interferon therapy for chronic viral hepatits. Diabetes Res. clin. Pract. 23 (1994), 33-36.
99. Wandl, U. B., M. Nagel-Hiemke, D. May, E. Kreuzfelder, O. Kloke, M. Kranzhoff, S. Seeber, N. Niederle: Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders. Clin. Immunol. Immunopath. 65 (1992), 70-74.
100. Watanabe, U., E. Hashimoto, T. Hisamitsu, H. Obata, N. Hayashi: The risk factor for development of thyroid disease during interferon-α therapy for chronic hepatitis C. Amer. J. Gastroent. 89 (1994), 399-403.
101. Weber, P., K. H. Wiedermann, R. Klein, E. Walter, H. E. Blum, P. A. Berg: Induction of autoimmune phenomena in patients with chronic hepatitis B infection treated with gamma-interferon. J. Hepatol, 20 (1994), 321-328.
102. Yoshikawa, M., T. Sakamoto, A. Mitoro, T. Mochi, H. Tsujii, M. Koizumi, H. Yoshiji, Y. Sakaguchi, H. Fukui, H. Nakano et al.: Autoimmunity during alpha-interferon therapy for chronic hepatitis C (Zusammenfassung). Gastroenr Jap. 28, Suppl. 5 (1993), 109-114.